Refine by
Therapeutic Benefit Equipment Supplied In Usa
27 equipment items found
by:Cartesian Therapeutics based inGaithersburg, MASSACHUSETTS (USA)
ImmTOR has significant potential to mitigate unwanted immune responses and induce AAV-specific tolerance to enable redosing of gene therapies. ImmTOR has the potential to administer multiple low doses to achieve therapeutic benefit without risk of overdosing, the ability to treat patients typically excluded from these treatments and is a novel approach to ...
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
The unique patented formulation has been designed to optimize the delivery and absorption of cyclobenzaprine for the therapeutic benefit of improving sleep quality, while minimizing the potential residual effects of oral formulations of cyclobenzaprine. TNX-102 SL is a centrally acting analgesic that helps in relieving pain by improving ...
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
The unique patented formulation has been designed to optimize the delivery and absorption of cyclobenzaprine for the therapeutic benefit of improving sleep quality, while minimizing the potential residual effects of oral formulations of cyclobenzaprine. TNX-102 SL is a centrally acting analgesic that helps in relieving pain by improving ...
Manufactured by:Vascugen Inc. based inMadison, WISCONSIN (USA)
Development of complex iPSC-based therapeutics benefits from an engineering mindset. Each layer of the development and manufacturing process is considered part of the ‘Full Stack’ that leads to finished product. An integrated stepwise approach improves the probability of arriving at the right therapeutic candidate and reduces ...
by:Caribou Biosciences, Inc. based inBerkeley, CALIFORNIA (USA)
We are developing differentiated, off-the-shelf CAR-T cell therapies, derived from healthy donor T cells, that are genome-edited to improve persistence of antitumor activity and potential therapeutic benefit. ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Gain is utilizing its Site-Directed Enzyme Enhancement Therapy (See-Tx™) platform to guide misfolded enzymes back into their proper shape in order to treat a range of diseases. ...
Manufactured by:EMulate Therapeutics, Inc. based inBellevue, WASHINGTON (USA)
Mensana is feasibility (phase I) trial ready for treatment of PTSD, depression, anxiety and addiction by the application of specific psychoactive ulRFE fields, another expression of EMulate’s Therapeutic technology. ...
Manufactured by:PENTAX Medical based inTokyo, JAPAN
This combination allows for clear visualization, successfully enabling endosonographic diagnosis and advancing therapeutic procedures for the benefit of ...
Manufactured by:Advanced Brain Monitoring, Inc. based inCarlsbad, CALIFORNIA (USA)
Apnea Guard is a patented non-custom oral appliance that can be fitted in less than 15 minutes by any trained health professional and worn for up to 30 nights. The patented design utilizes a combination of tongue size and sex to select phenotypical features that achieve treatment outcomes superior to the conventional fitting of custom oral ...
Manufactured by:AMREX, Trademark of Amrex-Zetron Inc. based inParamount, CALIFORNIA (USA)
The SynchroSonic US/752 combination unit offers the benefits of therapeutic ultrasoundand high voltage muscle stimulation.The newly designed dual channel high voltage section provides four pad output, two intensity controls and bi-polar application. The SynchroSonic US/752 also features the new Cable Fault Alarm system. ...
Manufactured by:Lauren Sciences LLC based inNew York City, NEW YORK (USA)
V-Smart Platform, breakthrough innovation, winning trifecta for brain delivery, enables non-invasive, triple-targeted CNS delivery of non-BBB penetrant therapeutic agents (nucleic acids, antibodies, biologics, small molecules, ...
Manufactured by:InSilicoTrials Technologies based inStafford, VIRGINIA (USA)
PCa GnRH Agonists Simulator enables simulations of clinical trials on a virtual population of prostate cancer patients being treated with a GnRH agonist ...
Manufactured by:QXMedical based inMontreal, QUEBEC (CANADA)
Biodegradable QXMédical Xpheres Microspheres are the next-generation embolics designed to address the evolving needs in the field of embolization therapy, interventional radiology and interventional radiology ...
Manufactured by:AxioBionics based inAnn Arbor, MISSISSIPPI (USA)
The Wearable Therapy system by AxioBionics is a distinctive approach to rehabilitation and pain management that combines various surface electrical stimulation technologies such as TENS, NMES, and FES integrated with a customized garment. This system is tailored to deliver personalized therapy to patients with medically complex conditions. Primarily designed to enhance muscle activity throughout ...
by:Sumitomo Pharma Oncology, Inc. based inCambridge, MASSACHUSETTS (USA)
Dubermatinib (TP-0903) is an investigational inhibitor of AXL receptor tyrosine kinase (RTK), a protein known to be involved in acquiring resistance to chemotherapeutics, immune evasion, and developing metastatic capacity in cancer ...
Manufactured by:Kaio Therapy, LLC based inRaleigh, NORTH CAROLINA (USA)
Kaio Therapy's Immune Activation Heat Therapy is a novel hyperthermia system that delivers precisely controlled heat at the cellular level within a tumor. Because Kaio’s IAHT elegantly induces necrosis while activating a systemic, tumor specific response, it can also serve as a platform for other immunotherapies seeking higher efficacies, broader markets and competitive advantage within the ...
Manufactured by:POP Biotechnologies, Inc. (POP BIO) based inBuffalo, NEW YORK (USA)
PhotoDOX is a revolutionary cancer therapy designed to address solid tumors which are resistant to current standards of care through the innovative benefits of the light-activated PoP-liposome drug delivery ...
Manufactured by:Fate Therapeutics, Inc. based inSan Diego, CALIFORNIA (USA)
Multiple myeloma is a hematologic malignancy characterized by the proliferation of malignant plasma cells. In multiple myeloma, malignant plasma cells accumulate in the bone marrow and produce abnormal antibodies called M proteins, which can cause kidney damage, bone destruction, and impaired immune function. While multiple approved drugs with novel mechanisms have improved disease management ...
by:Longeveron, Inc. based inMiami, FLORIDA (USA)
Lomecel-B is made from special living cells called Medicinal Signaling Cells, or MSCs that are isolated from fresh bone marrow tissue that has been donated by adult donors aged 18 to 45. Because the cells come from another individual, Lomecel-B is referred to as an “allogeneic” (donor-derived) ...
Manufactured by:Ocugen, Inc. based inMalvern, PENNSYLVANIA (USA)
OCU400 (AAV-NR2E3) is a novel gene therapy product candidate with the potential to be broadly effective in restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases (“IRDs”). It consists of a functional copy of a nuclear hormone receptor (“NHR”) gene, NR2E3, delivered to target cells in the retina using an adeno-associated ...